相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Role of the Iron Protoporphyrins Heme and Hematin in the Antimalarial Activity of Endoperoxide Drugs
Helenita C. Quadros et al.
PHARMACEUTICALS (2022)
Biological Evaluation in Resistant Cancer Cells and Study of Mechanism of Action of Arylvinyl-1,2,4-Trioxanes
Jerome P. L. Ng et al.
PHARMACEUTICALS (2022)
Streamlined and Robust Stage-Specific Profiling of Gametocytocidal Compounds Against Plasmodium falciparum
Janette Reader et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2022)
Clinical and In Vitro Resistance of Plasmodium falciparum to Artesunate- Amodiaquine in Cambodia
Melissa Mairet-Khedim et al.
CLINICAL INFECTIOUS DISEASES (2021)
Synthesis, computational docking and biological evaluation of celastrol derivatives as dual inhibitors of SERCA and P-glycoprotein in cancer therapy
Paolo Coghi et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
Artemisinin Mediates Its Tumor-Suppressive Activity in Hepatocellular Carcinoma Through Targeted Inhibition of FoxM1
Deeptashree Nandi et al.
FRONTIERS IN ONCOLOGY (2021)
The Artemiside-Artemisox-Artemisone-M1 Tetrad: Efficacies against Blood Stage P. falciparum Parasites, DMPK Properties, and the Case for Artemiside
Liezl Gibhard et al.
PHARMACEUTICS (2021)
Toward New Transmission-Blocking Combination Therapies: Pharmacokinetics of 10-Amino-Artemisinins and 11-Aza-Artemisinin and Comparison with Dihydroartemisinin and Artemether
Daniel J. Watson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)
Celastrol Modulates Multiple Signaling Pathways to Inhibit Proliferation of Pancreatic Cancer via DDIT3 and ATF3 Up-Regulation and RRM2 and MCM4 Down-Regulation
Mahmoud Youns et al.
ONCOTARGETS AND THERAPY (2021)
Nanotechnology-Based Celastrol Formulations and Their Therapeutic Applications
Pushkaraj Rajendra Wagh et al.
FRONTIERS IN PHARMACOLOGY (2021)
Recent progress in nanotechnology-based drug carriers for celastrol delivery
Ling Guo et al.
BIOMATERIALS SCIENCE (2021)
Artemisinin-type drugs for the treatment of hematological malignancies
R. Mancuso et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2021)
Biosynthesis, total synthesis, structural modifications, bioactivity, and mechanism of action of the quinone-methide triterpenoid celastrol
Yun Lu et al.
MEDICINAL RESEARCH REVIEWS (2021)
Antimalarial N1,N3-Dialkyldioxonaphthoimidazoliums: Synthesis, Biological Activity, and Structure-activity Relationships
Stephen Ahenkorah et al.
ACS MEDICINAL CHEMISTRY LETTERS (2020)
Metabolomics Reveals that Cysteine Metabolism Plays a Role in Celastrol-Induced Mitochondrial Apoptosis in HL-60 and NB-4 Cells
Minjian Chen et al.
SCIENTIFIC REPORTS (2020)
Optimal 10-Aminoartemisinins With Potent Transmission-Blocking Capabilities for New Artemisinin Combination Therapies-Activities Against Blood Stage P. falciparum Including PfKI3 C580Y Mutants and Liver Stage P. berghei Parasites
Ho Ning Wong et al.
FRONTIERS IN CHEMISTRY (2020)
Preparation of high drug-loading celastrol nanosuspensions and their anti-breast cancer activities in vitro and in vivo
Tiantian Huang et al.
SCIENTIFIC REPORTS (2020)
Artemisinin and its derivatives: a promising cancer therapy
Bushra Hafeez Kiani et al.
MOLECULAR BIOLOGY REPORTS (2020)
'Artemisinin Resistance': Something New or Old? Something of a Misnomer?
Thomas E. Wellems et al.
TRENDS IN PARASITOLOGY (2020)
Artemisinins as a novel anti-cancer therapy: Targeting a global cancer pandemic through drug repurposing
Yolanda Augustin et al.
PHARMACOLOGY & THERAPEUTICS (2020)
Anti-Melanoma Activities of Artemisone and Prenylated Amino-Artemisinins in Combination With Known Anticancer Drugs
Ho Ning Wong et al.
FRONTIERS IN PHARMACOLOGY (2020)
Celastrol: A Review of Useful Strategies Overcoming its Limitation in Anticancer Application
Jinfeng Shi et al.
FRONTIERS IN PHARMACOLOGY (2020)
Anti-Cancer Effects of Pristimerin and the Mechanisms: A Critical Review
Jia-jun Li et al.
FRONTIERS IN PHARMACOLOGY (2019)
Combination Therapies of Artemisinin and its Derivatives as a Viable Approach for Future Cancer Treatment
Maushmi S. Kumar et al.
CURRENT PHARMACEUTICAL DESIGN (2019)
Prooxidative Activity of Celastrol Induces Apoptosis, DNA Damage, and Cell Cycle Arrest in Drug-Resistant Human Colon Cancer Cells
Helena Moreira et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2019)
Ozonide Antimalarials Alkylate Heme in the Malaria Parasite Plasmodium falciparum
Carlo Giannangelo et al.
ACS INFECTIOUS DISEASES (2019)
The anti-malarial drug artesunate causes cell cycle arrest and apoptosis of triple-negative MDA-MB-468 and HER2-enriched SK-BR-3 breast cancer cells
Anna L. Greenshields et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2019)
Artemisone and Artemiside Are Potent Panreactive Antimalarial Agents That Also Synergize Redox Imbalance in Plasmodium falciparum Transmissible Gametocyte Stages
Dina Coertzen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Facile Preparation of N-Glycosylated 10-Piperazinyl Artemisinin Derivatives and Evaluation of Their Antimalarial and Cytotoxic Activities
Yuet Wu et al.
MOLECULES (2018)
Oxidative stress and protein damage responses mediate artemisinin resistance in malaria parasites
Frances Rocamora et al.
PLOS PATHOGENS (2018)
A Mechanistic Overview of Triptolide and Celastrol, Natural Products from Tripterygium wilfordii Hook F
Shao-Ru Chen et al.
FRONTIERS IN PHARMACOLOGY (2018)
Artemisinin kills malaria parasites by damaging proteins and inhibiting the proteasome
Jessica L. Bridgford et al.
NATURE COMMUNICATIONS (2018)
Plasmodium falciparum resistance to artemisinin-based combination therapies: A sword of Damocles in the path toward malaria elimination
Manel Ouji et al.
PARASITE (2018)
Challenges to replace ACT as first-line drug
Aung Pyae Phyo et al.
MALARIA JOURNAL (2017)
The clinical impact of artemisinin resistance in Southeast Asia and the potential for future spread
Charles J. Woodrow et al.
FEMS MICROBIOLOGY REVIEWS (2017)
Cancer combination therapies with artemisinin-type drugs
Thomas Efferth
BIOCHEMICAL PHARMACOLOGY (2017)
Inhibition of the Flavin-Dependent Monooxygenase Siderophore A (SidA) Blocks Siderophore Biosynthesis and Aspergillus fumigatus Growth
Julia S. Martin del Campo et al.
ACS CHEMICAL BIOLOGY (2016)
The Redox Cycler Plasmodione Is a Fast-Acting Antimalarial Lead Compound with Pronounced Activity against Sexual and Early Asexual Blood-Stage Parasites
Katharina Ehrhardt et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Endoperoxide Drug Cross-Resistance Patterns for Plasmodium falciparum Exhibiting an Artemisinin Delayed-Clearance Phenotype
A. Siriwardana et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Redox Polypharmacology as an Emerging Strategy to Combat Malarial Parasites
Pavel Sidorov et al.
CHEMMEDCHEM (2016)
Methylene Homologues of Artemisone: An Unexpected Structure-Activity Relationship and a Possible Implication for the Design of C10-Substituted Artemisinins
Yuet Wu et al.
CHEMMEDCHEM (2016)
Artesunate induces apoptosis via a ROS-independent and Bax-mediated intrinsic pathway in HepG2 cells
Guiqi Qin et al.
EXPERIMENTAL CELL RESEARCH (2015)
Nowhere to hide: interrogating different metabolic parameters of Plasmodium falciparum gametocytes in a transmission blocking drug discovery pipeline towards malaria elimination
Janette Reader et al.
MALARIA JOURNAL (2015)
In vitro anti-cancer effects of artemisone nano-vesicular formulations on melanoma cells
Anupma Dwivedi et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2015)
A molecular mechanism of artemisinin resistance in Plasmodium falciparum malaria
Alassane Mbengue et al.
NATURE (2015)
Potent Plasmodium falciparum Gametocytocidal Activity of Diaminonaphthoquinones, Lead Antimalarial Chemotypes Identified in an Antimalarial Compound Screen
Takeshi Q. Tanaka et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Anticancer effect of antimalarial artemisinin compounds
A. K. Das
ANNALS OF MEDICAL AND HEALTH SCIENCES RESEARCH (2015)
1,4-Naphthoquinones: From Oxidative Damage to Cellular and Inter-Cellular Signaling
Lars-Oliver Klotz et al.
MOLECULES (2014)
Evidence for NQO1 and NQO2 catalyzed reduction of ortho- and para-quinone methides
H. R. Kucera et al.
FREE RADICAL RESEARCH (2013)
Anticancer Properties of Distinct Antimalarial Drug Classes
Rob Hooft van Huijsduijnen et al.
PLOS ONE (2013)
Celastrol Analogues as Inducers of the Heat Shock Response. Design and Synthesis of Affinity Probes for the Identification of Protein Targets
Lada Klaic et al.
ACS CHEMICAL BIOLOGY (2012)
Interactions between Artemisinins and other Antimalarial Drugs in Relation to the Cofactor Model-A Unifying Proposal for Drug Action
Richard K. Haynes et al.
CHEMMEDCHEM (2012)
Exploring the trifluoromenadione core as a template to design antimalarial redox-active agents interacting with glutathione reductase
Don Antoine Lanfranchi et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2012)
In vitro study of the anti-cancer effects of artemisone alone or in combination with other chemotherapeutic agents
Andrew M. Gravett et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2011)
Reactions of Antimalarial Peroxides with Each of Leucomethylene Blue and Dihydroflavins: Flavin Reductase and the Cofactor Model Exemplified
Richard K. Haynes et al.
CHEMMEDCHEM (2011)
Discovery of Novel Alkylated (bis)Urea and (bis)Thiourea Polyamine Analogues with Potent Antimalarial Activities
Bianca K. Verlinden et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Quantitative assessment of Plasmodium falciparum sexual development reveals potent transmission-blocking activity by methylene blue
Sophie H. Adjalley et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Facile Oxidation of Leucomethylene Blue and Dihydroflavins by Artemisinins: Relationship with Flavoenzyme Function and Antimalarial Mechanism of Action
Richard K. Haynes et al.
CHEMMEDCHEM (2010)
Discovery, mechanisms of action and combination therapy of artemisinin
Liwang Cui et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2009)
New medicines to improve control and contribute to the eradication of malaria
Timothy N. C. Wells et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Artemisinin-based combination therapies: a vital tool in efforts to eliminate malaria
Richard T. Eastman et al.
NATURE REVIEWS MICROBIOLOGY (2009)
First assessment in humans of the safety, tolerability, pharmacokinetics, and ex vivo pharmacodynamic antimalarial activity of the new artemisinin derivative artemisone
Johannes Nagelschmitz et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Experimental therapy of hepatoma with artemisinin and its derivatives:: In vitro and in vivo activity, chemosensitization, and mechanisms of action
Junmei Hou et al.
CLINICAL CANCER RESEARCH (2008)
Interactions of methylene blue with human disulfide reductases and their orthologues from Plasmodium falciparum
Kathrin Buchholz et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Antimalarial efficacy and drug interactions of the novel semi-synthetic endoperoxide artemisone in vitro and in vivo
L. Vivas et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Artemisone - A highly active antimalarial drug of the artemisinin class
RK Haynes et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2006)
In vitro assessment of methylene blue on chloroquine-sensitive and -resistant Plasmodium falciparum strains reveals synergistic action with artemisinins
M Akoachere et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Highly antimalaria-active artemisinin derivatives: Biological activity does not correlate with chemical reactivity
RK Haynes et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2004)
Modified fixed-ratio isobologram method for studying in vitro interactions between atovaquone and proguanil or dihydroartemisinin against drug-resistant strains of Plasmodium falciparum
QL Fivelman et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Simple and inexpensive fluorescence-based technique for high-throughput antimalarial drug screening
M Smilkstein et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Assessment of azithromycin in combination with other antimalarial drugs against Plasmodium falciparum in vitro
C Ohrt et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
In vitro interactions of artemisinin with atovaquone, quinine, and mefloquine against Plasmodium falciparum.
S Gupta et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
分享论文
